| Literature DB >> 29080803 |
N K Singhal1, E Freeman2, E Arning3, B Wasek3, R Clements2, C Sheppard4, P Blake4, T Bottiglieri3, J McDonough2.
Abstract
We report a significant reduction in plasma methionine concentrations in relapse remitting multiple sclerosis (MS) patients compared to controls. In vivo studies demonstrate that changes in peripheral methionine levels in mice can regulate histone H3 methylation and expression of DNA methyltransferase 3A (DNMT3A) centrally, in the cerebral cortex. Therefore, we propose that decreases in circulating methionine represent one of the earliest manifestations of dysregulated methionine metabolism in MS with potential impacts on both histone H3 and DNA methylation in the central nervous system.Entities:
Keywords: DNA methyltransferases; Histone methylation; Methionine metabolism; Multiple sclerosis
Mesh:
Substances:
Year: 2017 PMID: 29080803 DOI: 10.1016/j.neuint.2017.10.011
Source DB: PubMed Journal: Neurochem Int ISSN: 0197-0186 Impact factor: 3.921